AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,650 | -83.9% | 29,556 | -77.2% | 0.00% | -66.7% |
| Q1 2023 | $1,423,485 | +1985.5% | 129,880 | +722.0% | 0.00% | – |
| Q4 2022 | $68,256 | -92.0% | 15,800 | -86.1% | 0.00% | -100.0% |
| Q3 2022 | $856,000 | +14.1% | 113,890 | +52.5% | 0.00% | 0.0% |
| Q2 2022 | $750,000 | +131.5% | 74,674 | +185.1% | 0.00% | +200.0% |
| Q1 2022 | $324,000 | -2.1% | 26,188 | +81.1% | 0.00% | 0.0% |
| Q4 2021 | $331,000 | -83.6% | 14,461 | -84.2% | 0.00% | -85.7% |
| Q3 2021 | $2,023,000 | +436.6% | 91,382 | +214.0% | 0.01% | +250.0% |
| Q2 2021 | $377,000 | +17.1% | 29,103 | +17.4% | 0.00% | +100.0% |
| Q1 2021 | $322,000 | +41.9% | 24,800 | +77.3% | 0.00% | 0.0% |
| Q2 2020 | $227,000 | -20.6% | 13,987 | -29.1% | 0.00% | -50.0% |
| Q1 2020 | $286,000 | -82.9% | 19,722 | -76.1% | 0.00% | -83.3% |
| Q4 2019 | $1,671,000 | +3052.8% | 82,500 | +725.0% | 0.01% | – |
| Q3 2019 | $53,000 | -34.6% | 10,000 | -18.9% | 0.00% | -100.0% |
| Q2 2019 | $81,000 | +22.7% | 12,325 | +22.0% | 0.00% | 0.0% |
| Q1 2019 | $66,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |